Article
Cover
RJAS Journal Cover Page

RGUHS Nat. J. Pub. Heal. Sci Vol No: 11 Issue No: 1  pISSN: 2249-2194

Article Submission Guidelines

Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.

Review Article
Vinay M Raole*,1, Vaidehi V Raole2,

1Vinay M Raole, Department of Botany, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujrat, India.

2Department of Sharir Kriya, Parul Institute of Ayurveda, Parul University, Limda, Waghodia, Vadodara, Gujrat, India

*Corresponding Author:

Vinay M Raole, Department of Botany, Faculty of Science, The Maharaja Sayajirao University of Baroda, Vadodara, Gujrat, India., Email: vinaysar@rediffmail.com
Received Date: 2023-03-21,
Accepted Date: 2023-11-08,
Published Date: 2024-06-30
Year: 2024, Volume: 11, Issue: 1, Page no. 28-37, DOI: 10.26463/rjas.11_1_11
Views: 494, Downloads: 13
Licensing Information:
CC BY NC 4.0 ICON
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0.
Abstract

Ayurveda is getting its due recognition at worldwide forums due to its ancient philosophy, even though the medical and scientific fraternity around the globe has a very strong opinion regarding the safety and efficacy of Ayurvedic medicines. The provisions of Intellectual Property Rights under the World Intellectual Property Organization and patents have drawn interest from many individuals and organizations seeking commercial benefits from Ayurvedic traditional knowledge. However, there are numerous challenges related to protecting traditional medical knowledge, with unclear explanations. Efforts to safeguard traditional medicine face a complex array of national and international policies and governance systems primarily designed to address therapeutic efficacy, safety concerns, and challenges to rights held by traditional knowledge holders. Traditional knowledge has been categorized into three classes: 1. Traditional medical knowledge, 2. Traditional agricultural knowledge 3. Traditional ecological knowledge. This text is an attempt to assist traditional medical knowledge holders, government representatives, and third-party collaborators considering intellectual property law issues specifically related to traditional medical knowledge. Whether traditional healing knowledge is documented can significantly impact intellectual property protection, commercialization, promotion of traditional medicine, regulatory submissions, and collaborations. It's crucial for traditional knowledge holders to be well-informed to protect their reputations and interests when engaging with third parties. This understanding can empower them to navigate the complexities of traditional medicine and intellectual property, enabling informed decisions on how best to utilize their knowledge.

<p>Ayurveda is getting its due recognition at worldwide forums due to its ancient philosophy, even though the medical and scientific fraternity around the globe has a very strong opinion regarding the safety and efficacy of Ayurvedic medicines. The provisions of Intellectual Property Rights under the World Intellectual Property Organization and patents have drawn interest from many individuals and organizations seeking commercial benefits from Ayurvedic traditional knowledge. However, there are numerous challenges related to protecting traditional medical knowledge, with unclear explanations. Efforts to safeguard traditional medicine face a complex array of national and international policies and governance systems primarily designed to address therapeutic efficacy, safety concerns, and challenges to rights held by traditional knowledge holders. Traditional knowledge has been categorized into three classes: 1. Traditional medical knowledge, 2. Traditional agricultural knowledge 3. Traditional ecological knowledge. This text is an attempt to assist traditional medical knowledge holders, government representatives, and third-party collaborators considering intellectual property law issues specifically related to traditional medical knowledge. Whether traditional healing knowledge is documented can significantly impact intellectual property protection, commercialization, promotion of traditional medicine, regulatory submissions, and collaborations. It's crucial for traditional knowledge holders to be well-informed to protect their reputations and interests when engaging with third parties. This understanding can empower them to navigate the complexities of traditional medicine and intellectual property, enabling informed decisions on how best to utilize their knowledge.</p>
Keywords
Intellectual property, Patent, Traditional medicine, TRIPS, WTO
Downloads
  • 1
    FullTextPDF
Article
Introduction

Customary information is by and large thought to be the aggregate legacy of a specific native individual or neighbourhood local area. Conventional clinical information, like the therapeutic utilization of plant taxa, is regularly connected with hereditary assets. Customary clinical information has social, social, and logical worth and is significant for some native groups and local area networks. Developing business and logical interest in conventional medication frameworks has prompted calls for accustomed clinical information to be better perceived, regarded, saved, and safeguarded. Medical science has generally stayed in ceaseless pursuit of a solitary reason for an illness, be it physical, physiological, or mental. On the hand, Ayurveda, the Indian conventional clinical context, has generally looked at illnesses as an all-encompassing reaction of a person to a natural test. The widespread utilization of customary information and abilities to manage the inconstancy of well-being needs exists across societies all over the globe. Across societies, ordinary customary medication is continuously coordinating the enthusiastic, physical, mental, and other worldly qualities of a person. This has generally assisted with re-establishing a condition of foundational balance between the individual and nature. Man since the dawn of time, has continually battled in and around the normal world for the abundance given by a lot of assets including endless plants and plant products that constantly assisted us with arriving at the objective. Nature gave man every one of the essential prerequisites for his reality, and for that reason nature is regarded as ‘mother earth’. Plantor organism-based medication is the primary source of healthcare worldwide.1

Concept of Ayurveda

Ayurveda isn't folklore or a home-based custom; it is a characteristic arrangement of medical care that began in India 5000 years prior. The old traditional medication framework, Ayurveda, was pointed essentially to advance well-being, be that as it may, as opposed to battle against illnesses. The most prehistoric writing on the planet is sacrosanct Rigveda, which contains 1,028 hymns. The antiquated text Rigveda and Atharvaveda range from 4000 B.C. to 2500 B.C. to 1500 B.C., with the last option date being most often referenced by students of history.2 Ayurveda is referenced as a subpart of Atharvaveda. Ayurveda is a deep-rooted Indian recuperating framework amidst a customized approach. Likewise, it is very much reported and rehearsed in the public arena for a long time. Ayurveda isn't simply legends or a nearby legendary custom; it is an acknowledged and very much planned arrangement of medical care that began in India over 5000 years ago. It generally focuses on the treatment of ailment in an exceptionally individualized way as it accepts that each individual has a one-of-a-kind specific constitution. Given the hypothesis of tridosha, three doshas, Vata (connected with space and air), Pitta (fire and water), and Kapha (water and earth) characterizes all individuals into various sorts of 'Prakriti' with each kind having a fluctuating level of inclination to various afflictions. As per Ayurvedic provisions, Prakriti is fixed at the hour of birth of an individual and stays invariant all through the life expectancy of the person. According to the tridosha principle, each person is born with a primary inherent characteristic that mainly determines their susceptibility to diseases and their response to the prevailing external environment, diet, and medications (All Laghutrayees and Bruhatrayees). This is generally autonomous of geological, racial, or ethnic contemplations. Each individual has different levels of these doshas, leading to variations among people. Whether this phenotypic order has a biomolecular basis has been a subject of debate. A few studies have found some connections when examining specific genes. Assessing diverse traits of an individual, such as anatomy, physiology, and mental fitness, can aid in the evaluation of Prakriti. At the morphological and physical level, individuals may differ in body shape and structure, as well as in skin, eye, and hair color. The irregularity was seen at physiological levels, including food propensities and stomach-associated ability of a particular individual in addition to resemblance to put on weight, illness conflict, and therapeutic capacity.3

The World Health Organization characterizes accustomed or complementary medication as "the amount of the information, abilities, and practices upheld the hypotheses, convictions, and encounters native to various societies, regardless of whether intelligible, used in the upkeep of wellbeing, as well as in the anticipation, analysis, improvement or treatment of physical and psychological sicknesses".4

Accustomed clinical information has social, social and logical worth and is significant for some native groups and nearby areas. Developing business and logical interest in customary medication frameworks has prompted the contribution of conventional clinical information to be better perceived, regarded, protected, and monitored. With the establishment of the World Trade Organization on 1st January 1995, issues connecting with licensed innovation freedoms (IPRs) have come to the front in global exchange and business and domestic fully-fledged economy conversations and policymaking. This has impacted even regions like customary information, conventional medication, organic assets of a nation, and therapeutic and aromatic plants. The Agreement on Trade-Related Aspects of Intellectual property freedoms (TRIPS) shaped Annex 1C of the Agreement laying out the WTO. One of the agreements formed during the Uruguay Round (1986- 1994) of GATT (General Agreement on Tariffs and Trade) negotiations.4,5

Customary information has been arranged into three classes.

1. Traditional clinical information,

2. Traditional agrarian information,

3. Customary environmental information.

Lately, there has been an adjustment to the slogan of the old period of authorizing, for example 'Patent or die' which supplanted the slogan - 'distribute or die’. The world observes "Licensed Innovation Rights," each April and is given the slogan "Development Improves Lives". Modernization in Ayurveda undoubtedly further improves life, the creations must be investigated over a significant period. Ayurveda is known as the 'Medication of the thousand years.' It brings a ton to the table to accomplish well-being all around the world. Native information is the sub-class of the customary information classification which is utilized by networks, commoners, and countries. Local individuals all over the planet particularly from remote areas generally utilize traditional clinical information for their health-related issues.

Ayurveda is often recognized as the "Mother of all healing" that acquires concordance and equilibrium in all aspects of life including mind, body, profound prosperity, and social government assistance of humanity. Ayurveda is gaining its rightful recognition as a philosophical system of medicine worldwide. However, the medical and scientific communities around the globe have strong opposing views regarding the safety and efficacy of Ayurvedic medications. In the meantime, arrangements of Intellectual Property Rights under the World Intellectual Property Organization and licenses have drawn in numerous people and associations to investigate conceivable outcomes of business benefits with Ayurvedic customary information. Even though rules are not leaning towards allowing a patent on earlier distributed information, biopiracy oversaw the award of a patent for information on Ayurvedic therapeutic plants which has been effectively checked with references of the data set of Traditional Knowledge Digital Library.6

Herbals and established plant parts have generally been viewed as the origin of therapeutic purposes from days of yore. The vast majority of the conventional medication frameworks of the world depend on the healing properties of plants including plant parts. There is not a solitary plant that has no medicinal properties. Subsequently, the quantity of therapeutic plants differs between specialists. According to one estimate, there are more than 15,000 therapeutic plants in India of which 1500 find explicit notice and mention in the Indian Systems of Medicine like Ayurveda, Unani, and Siddha. As per a similar initiator, more than 500 of them are utilized in the preparation of the medications. According to another report, over 7,000 plants are known to be utilized for restorative, medicinal, and aromatic purposes in India. The therapeutic properties recorded in the texts of these ancient frameworks as well as the customary information passed on from generation to generation related to the plants have been a significant area for innovative work on new medicinal formulations or biomolecules in the allopathic medication. This framework is vigorously reliant upon patent insurance for the business creation of medicinal formulations or even biomolecules. Thus, a large portion of the new medications or new characteristics of a current medication in this framework has been protected under license. That likewise remembers information for the customary traditional systems of medication, which however was already obscure to present-day pharmaceutical specialists. In the book, Biopiracy: Imitations not Innovations, the Gene Campaign subtleties of 31 cases have been depicted in detail and reported by many scientific researchers including modern health practitioners.

Furthermore, licenses in light of natural assets are named 'biopiracy' by many initiators. It adds up to the misappropriation of a local area's/country's property without due authorization. To forestall such off-base licenses, the Indian Patents Act of 1970 has made explicit arrangements. According to Section 3, the following is not patentable: "Plants and animals in whole or any part thereof other than microorganisms but including seeds, varieties, and species and essentially biological processes for production or propagation of plants and animals.".7 "An invention which in effect is traditional knowledge or which is an aggregation or duplication of known properties of a traditionally known component or components."8 Apart from Indian frameworks of medication, Allopathic drugs additionally involve numerous Indian native and indigenous information on plants for making new medications as well as beauty care products. A rundown of licenses where chosen plants are involved is brought together in Table 1. Licensed innovation freedoms incorporate select privileges to a scope of theoretical resources and give financial advantages to the proprietor. Many works by individual artists, such as abstract and creative pieces, fall into this category. In addition, words, expressions, images, and plans in any structure have also been included.

Intellectual property rights (IPR) incorporates copyright, licenses, modern plans, brand names, proprietary advantages, and, surprisingly, electronic chips. IPR is a legitimate idea and is acknowledged at global discussions under the tutelage of World Trade Organization (WTO), World Intellectual Property Organization (WIPO), and Trade-Related Aspects of Intellectual Property Rights (TRIPS).

IPR is chiefly separated into scholarly and creative opportunities and brought out by the individual as well as safeguarded for at least 50 years even after the demise of the inventor or artist who performs and records their broadcasting songs, music, drama, etc. Modern industrial plans and property incorporate specific brand names (logo and unmistakable sign) and topographical pointers/signs (basically about the beginning of the spot/locality). The security of such unmistakable signs expects to invigorate and guarantee fair rivalry and to safeguard buyers, by empowering them to settle on informed decisions between different services and products. Different kinds of modern property (physical and industrial) are safeguarded essentially to strengthen advancement, plan, and the formation of innovation. In this classification, developments (safeguarded by licenses), modern plans, and proprietary innovations are incorporated. The social object is to safeguard the consequences of interest in the improvement of innovation, along these lines giving the motivating force and means to fund innovative work exercises. A working protected innovation system ought to likewise work with the exchange of innovation. A functioning intellectual property regime should also facilitate the transfer of technology in the form of foreign direct investment, joint ventures, and licensing. The insurance is normally given for a limited term (regularly 20 years on account of licenses).

Traditional knowledge and IPR

Customary information on all things considered - information that has old roots and is regularly casual and oral - isn't safeguarded by ordinary licensed innovation frameworks. This has incited a few nations to foster their generic such as an explicit and extraordinary framework for safeguarding society and cultural information. Lately, even the Indian government has passed rules and guidelines to safeguard the freedom of the neighbourhood as well as ancestral individuals. This has opened another vista to record the conventional and people information on each edge of our country. As a rule, it is intended for the economic turn of events and preservation of normal assets at the neighbourhood, provincial, and state levels. These drives are in progress and give the option to safeguard and disperse information to society all in all. All things considered, such drive makes customary information all the more generally accessible to the commoners. This will constantly make more logical and monetary issues because of misappropriation and utilized in numerous ways which got to on the web and the advantage is given to the information holder in those ancestral social orders or metropolitan culture. Simultaneously, documentation in any structure can assist with safeguarding conventional information, for instance, insofar as a private or mystery record of customary information saved for that particular applicable local area and society dwelling in that specific normal zone as it were. A few conventional documentation and vaults of customary information support sui generis security frameworks, while an enormous number of customary information data sets - like India's data set on conventional medication - assume a part in cautious insurance inside the current IP framework. One explicit model is Navara rice from Kerala which is an enlisted assortment. It is utilized in Ayurveda for explicit medicines like Panchakarma and different medicines for joint pain. These models exhibit the significance of guaranteeing that documentation of customary information is connected to a protected innovation technique and doesn't occur in an arrangement or legitimate vacuum. Another particular model is given underneath.

The Kani Case

This is one of the earliest reported instances of interest taking in licensed innovation freedoms given the conventional therapeutic information on plants of south India. Tropical Botanical Gardens and Institute (TBGRI) acquired information on the restorative properties of the Trichopus zeylanicus L. plant in 1987, preceding the order of the Biological Diversity Act, 2002, and the corrections to the Patents Act 2005. Kanis is a little ancestral local area on the Agastamalai slopes of South Kerala. In light of this information, the organization created and protected the medication Jeevani, a polyherbal item to support humanity. The Institute sold the item through Arya Vaidya Pharmacy in Coimbatore after assembling it industrially. The eminences from selling the Jeevani, half of the benefits were imparted to the Kani clan, and information was acquired from this clan through benefit-sharing benefits for access.9

IPR and Ayurveda

Conservative localized information is viewed as the result of individual inventiveness today; however knowledge was viewed as the most valuable gift to mankind. Notwithstanding, in India additionally, as in other non-industrial nations, there are a few moral and ethical issues excessively connected with protecting living organisms, the first sign being the degree of individual possession that could be reached out to living properties. One of the significant reasons for vulnerabilities and discussions connected with IPR assurance of living organisms is the absence of a laid-out training or standard operating procedures in safeguarding such living materials; however, any type has unmistakable market appreciation.10 Concerning India, there exists an enormous number of issues that should be tended to from many angles. There is a prerequisite to be taught in the business sectors and in this way the innovations foster a faultless comprehension of the significance of astute property assurance and insurance to the common man. There are no unmistakable approaches to the licensing of qualities, and DNA groupings in India, yet Indian innovators working here have been applying for licenses all over the globe.11

The IPR issues before India and accordingly the non-industrial nations incorporate the stand that must be taken on the discrepancy among discoveries and inventions within the biological differentiation inside the natural region. The definition and scope of patentable microorganisms, as well as the extent of patentability or protection of other living materials such as plants and animals, include patentable inventions involving living entities like viruses, bacteria, fungi, plasmids, vectors, and more. Be that as it may, there is no consistency in all nations, albeit miniature life forms are right now patentable in numerous nations, plant assortments are patentable or protectable under a solitary framework.12

Ayurveda is getting its expected acknowledgment as a reasoning system of medication worldwide albeit the clinical and logical society of the globe has an extremely amazing inverse assessment in regards to the security and adequacy of the Ayurvedic system. In the interim, arrangements of Intellectual Property Rights under the World Intellectual Property Organization and licenses have drawn in numerous people and associations to investigate conceivable outcomes of business benefits with Ayurvedic conventional information of yesteryears. Even though the rule even allowed a patent on earlier distributed knowledge and information, biopiracy dealt with an award of a patent on information on Ayurvedic restorative plants which has been effectively checked with references of the data set of Traditional Knowledge Digital Library.13,14

Current arrangements of the patent law of India are not accommodative to getting a patent on Ayurvedic medicaments. Medicines derived from Ayurveda are based on previous knowledge and for that reason not patentable. This amounts to an agreement to the philosophies of patent laws that are fundamental to the new IP regime. If we need to involve experts from fundamental science to ensure the quality, safety, and efficacy of Ayurvedic medications, there is a critical need to revise patent laws with practical and promotional provisions as outlined in the guidelines. This will empower more licenses on various drug, nutraceutical, and cosmeceutical goods and items given in Ayurveda literature. As each activity of the present world is focused on monetary standards plus economic value, so why do partners of Ayurveda ought to be denied it including in the locals and aboriginals? New creations would drive the acknowledgment of the system of Ayurveda as a worldwide arrangement of medication.

During the most recent twenty years, the utilization of Ayurveda and other traditional medicines has extended internationally and acquired a bad reputation. It has not just kept on being utilized for essential medical care of needy individuals in emerging nations, but has also additionally been utilized in nations where ordinary medication is prevalent in the public medical care framework. With the significant increase in the use of Traditional Medicines worldwide, especially in developed countries, concerns over safety, efficacy, and internal quality control of domestic medicines and traditional method-based treatments have become crucial issues for both healthcare providers and practitioners.

The examination should be an interaction that changes over information into data, data into information, and information into shrewdness. It should be more adjusted and far-reaching for the science. There should be equivalent accentuation on the scholarly, field, trial, and clinical exploration. It should be prepared to affect the fields of training, drug store, and practice in a significant way. Contemporary Ayurvedic academic researchers and analysts face challenges in disseminating information acquired from their research, as well as in utilizing and sharing data generated through inquiries in Ayurveda.14

Any investigation work becomes legitimate and broadly acknowledged when it is circulated in peer-survey chronicles. Documentation and distribution of examination discoveries is the fundamental issue faced by Ayurveda in the worldwide research field. There are multiple scattered evidences for the well-being and adequacy of Ayurveda drugs belonging with a large number of analysts and non-administrative bodies. To gather and distribute them in the modern world via a good publication is the need of the hour. However, there is very little research in basic and modern sciences related to Ayurveda being published. To figure out the reasoning behind this, an audit of the whole situation must be completed. India has a long history and customs as well as a rich legacy of utilizing Ayurvedic drugs for medical care and excellence in working on personal cosmetics with great satisfaction. India is likewise fortunate, maybe to have the most abundant supply of customary home-grown herbal restorative plants and remedies. Taskforce report of Planning Commission, 2000 stressed that "The current period is seeing a captivating revival in the customary arrangement of traditional and complementary medication".15,16

Issues of distribution of Ayurvedic explores can be perceived at the following levels. Level of exploration and experimentation in Ayurveda in India and at the worldwide level, Status of organizations directing examination and research in Ayurveda, Format and convention of Ayurvedic investigate, Status of Ayurvedic Journals and prerequisite of late coherent Journals, support for Ayurvedic studies from various sources.17 Defenders of Ayurveda must deal with an extra layer of complexity, since they are trying to understand how their system of medicine relates to patent laws and whether and how their knowledge needs to be defended; but few people have the legal, political and Ayurvedic expertise to assess these issues. For biomedical pharmaceutical production, there is a little more clarity. Before TRIPS and the 2005 Patents Act, bio prospectors from multinational pharmaceutical companies could develop and patent a product based on Ayurvedic knowledge.18

The challenge lies in how we can effectively integrate intellectual property law, biomedical science, and Ayurvedic science collaboratively. In today's world, navigating under the umbrella of a global treaty involves deciphering diverse interests from national, international, and corporate actors, which can be challenging. Some individuals may have observed practices of pharmaceutical business unfold in the new environment. That is, as Ayurvedic Vaidya’s and manufacturers produce new formulations and realign their practices in addition to property claims in Ayurveda.

One specific reference can be noted as an eye opener for all Ayurveda practitioners. The age of input and pocketing of knowledge about natural science and medicine between India and the developed nations dates back at least to the accumulation of the botanical text Hortus Indicus Malabaricus in the seventeenth century compiled by Hendrik Adriaan van Rheede. This twelve volume compendium describes and classifies plants of Malabar Kerala based on Ayurvedic knowledge and was compiled with the help of indigenous informants, primarily from the Ezhava tribes. The knowledge is totally indigenous, and belongs to Indians. Reddy has mentioned that Leiden botanical garden was created after following the Ezhava botanical classifications and medicinal garden schemes. Now the Ezhava community has staked the claim on ownership of this.19

Another example of the appropriation of biological knowledge from the Indian subcontinent comes from a more recent period, and this time between Ayurvedic and biomedical psychiatry. In 1958, the American psychiatrist Nathan Kline declared that psycho-pharmaceutical drugs were reducing the inpatients in mental hospitals for the first time in the history of mental health care. The principle drug was reserpine, an alkaloid derived from the plant Rauwolfia serpentina, which has long been used in India in the treatment of mental disorders.20-,22 This medication continues to be prescribed, but now more as an antihypertensive rather than an antipsychotic. Various pharmaceutical multinationals are using this under the name Serpasil and Adelphane. Ciba-Geigy, later Novartis, generated hundreds of millions of dollars in sales over time. Rauwolfia serpentina, from which reserpine was derived, is still used by Ayurvedic physicians, and it is popularly known in India by its Sanskritic name “Sarpagandha.” This is provocatively reflected in Sandoz’s trademarked brand name for one of its reserpine products, Serpasil, a product still traded as Sandoz product is a hint to the contribution from India, another form of intellectual property.18,21

Issues in Ayurvedic research

Research is crucial for advancing modern Ayurveda; however, current research outcomes in Ayurveda have not been very rewarding for the field itself. Majority of it utilizes Ayurveda to expand present-day bioscience investigations. Interestingly, Ayurveda needs research intended to survey and approve its central ideas as well as its medicines and formulations. In this unique circumstance, assuming Ayurveda must be genuinely investigated and approved in the entirety of its angles, logical information sources ought to adjust to Ayurveda's standards and reasoning with modern scientific tools. While the evidence base, established since ancient times, may require further investigation, current research should focus on advancing the science of Ayurveda beyond merely exploring new herbal medicines. In-depth exploration and rigorous studies are needed to enhance our understanding of Ayurveda. Ayurveda research philosophy requires the 'entire framework testing approach', worldwide support with conventions advanced through the serious point of interaction with present-day science, administrative changes to kill boundaries and to be examined 'for all intents and purposes, utilizing approaches adjusted from its essential standards as well as basic principles.25

Though traditional knowledge as such has prehistoric roots and is often informal and oral, it is not secured by conventional knowledge holders. While somebody innovates within the customary information framework, they use the patent system to protect their innovations. This therefore has encouraged some nations to develop their own sui generis systems for shielding their traditional knowledge.24 By and large, in modern era, there are many initiatives in progress to document traditional knowledge in a most appropriate manner. At the same time, records can support and protect the traditional knowledge for the relevant community only. Moreover, India's database on traditional medicine - play a role in defensive protection within the existing IP system. Thus, it demonstrates the importance of documentation of traditional knowledge is an intellectual property strategy.25,26

Ayurveda is getting its due recognition as a rational system of medicine worldwide. Meanwhile, provisions of Intellectual Property Rights under the World Intellectual Property Organization and patents have attracted many individuals and organizations. Although rules are not favouring to grant a patent, biopiracy managed the grant of a patent on knowledge of Ayurvedic medicinal plants from the database of the Traditional Knowledge Digital Library.

Pharmaceuticals derived from Ayurveda are based on prior knowledge and therefore not patentable. This amounts to an agreement to the principles of patent law that are central to the new IP regime. Furthermore, current provisions of the patent law of India are not conducive to get a patent on Ayurvedic medicines.27,28 Hence, there is an urgent need to amend laws of patent with realistic promotional policies. This will encourage more patents on Ayurveda for many therapeutic, nutraceutical, and cosmeceutical products. As every action of today's world is based on economic criteria, so why stakeholders of Ayurveda should be deprived of it? With the tremendous development in the use of Customary Medicines worldwide in developed countries, safety and efficacy as well as quality control of herbal medicines have become important concerns for both health authorities and practitioners.29

Therefore, Ayurveda research should be a procedure that changes data into information, information into knowledge, and knowledge into wisdom. It need to be more balanced and comprehensive. There must be equal emphasis on literary, field, investigational, and scientific clinical research. Contemporary Ayurvedic researchers are failing in this detail as they are unable to publicize the knowledge gained from their research. As we are aware, any research effort becomes valid and extensively accepted when it is circulated in peer review journals. Certification and publication of research outcomes is the main problem faced by Ayurveda in the global arena. There are countless dispersed pieces of evidence from various practitioners, researchers and non-governmental organizations. So to collect and publish them is the need of the hour. On the other hand, very few research works on Ayurveda are being available in a printed form.23

Ayurvedic research methodology necessitates a holistic approach to testing, global participation with protocols developed through close collaboration with modern science, regulatory reforms to remove barriers, and investigation of Ayurveda in its entirety, employing approaches derived from its foundational principles.27 Much of Ayurveda research is an extended modern bioscience. In contrast, Ayurveda needs research designed to test and validate its important concepts as well as its cures. Moreover, scientific inputs must follow Ayurveda standards and philosophy. In this context, for Ayurveda to be thoroughly explored and validated across all its aspects, scientific inputs should align with Ayurveda's principles and philosophy. While its ancient evidence base may require further verification, research should prioritize advancing the scientific understanding of Ayurveda.30

Conclusion

India is perhaps the most diverse nation concerning natural and social changeability with various cultures. It is a fundamental center point of customary information and an exceptional endowment of neglected potential for advancing and utilizing conventional scientific information in antiquated times. The principal rule for social, social and monetary progression is to implement scholarly creation from all angles of Ayurveda. This paper investigated in short the IPR and security of traditional knowledge (TK) including traditional medical knowledge (TMK). The organization of IP and IPR is a multi-faceted errand and calls for a wide range of activities and procedures which should be aligned with public regulations and worldwide deals and practices. In the conventional social setting, Indians have significant issues fixing financial worth to whatever is certifiably not a substantial actual property that has market value.19 Thus, there is a pressing requirement for emerging nations like India to characterize clear approaches for IPR in the event of logical and technological developments. Regardless of the upsides of the innovation upheaval, genuine, lawful, moral, social, monetary, and humanistic issues and concerns are raised. Traditional information holders should be enough educated to defend their ill repute and interests while associating with outsiders as a third party. Customary knowledge is incorporated into their approaches to everyday life and has become comprehensive, accordingly is an indivisible part of the networks. The assurance of this information framework henceforth is indispensable for the actual presence of the native and nearby networks. So the protection of this knowledge system is vital for the very existence of the indigenous and local communities.

Conflict of Interest

None

Supporting File
No Pictures
References
  1. Patwardhan B, Warude D, Pushpangadan P, et al. Ayurveda, and traditional Chinese medicine: A comparative overview. eCAM 2005;2(4):465-473. 
  2. Tipton CM. Suhsruta of India, an unrecognized contributor to the history of exercise physiology. J Appl Physiol 2008;104:1553-1556.
  3. Hankey A. A test of the systems analysis underlying the scientific theory of Ayurveda's Tridosha. J Altern Complement Med 2005;11(3):385-390.
  4. Hankey A. Ayurvedic physiology and etiology: Ayurveda Amritanaam. The doshas and their functioning in terms of contemporary biology and physical chemistry. J Altern Complement Med 2001;7(5):567-574.
  5. World Trade Organization. What is the WTO? [Internet]. World Trade Organization. 2024. Available from: https://www.wto.org/english/ thewto_e/whatis_e/whatis_e.htm
  6. World Health Organization. WHO traditional medicine strategy: 2014-2023 [Internet]. www. who.int. 2013. Available from: https://www.who. int/publications/i/item/9789241506096
  7. WIPO. Diplomatic Conference on Proposed Treaty on Intellectual Property, Genetic Resources and Associated Traditional Knowledge to be held in May 2024 at WIPO’s Geneva Headquarters[Internet]. [cited 2003 Dec 13]. Available from: https://www. wipo.int/pressroom/en/articles/2023/article_0015. html
  8. Indian Patent Act 1970-Sections [Internet]. Ipindia. gov.in. 2017. Available from: https://ipindia.gov.in/ writereaddata/Portal/ev/sections-index.html
  9. The Biological Diversity Act, 2002 [Internet]. National Biodiversity Authority. [cited 2024 Jun 27]. Available from: http://nbaindia.org/uploaded/ pdf/cleanBDACT.pdf
  10. Agreement on Trade-Related Aspects of Intellectual Property Rights [Internet]. WTO. [cited 2024 Jun 27]. Available from: https://www.wto.org/english/ tratop_e/trips_e/ta_docs_e/1_tripsagreement_e.pdf 
  11. The Patents Rules, 2003 [Internet]. Intellectual Property India. 2017 [cited 2024 Jun 27]. Available from: https://upload.indiacode.nic.in/ showfile?actid=AC_CEN_11_61_00002_19703 9_1517807321764&type=rule&filename=ThePatents-Rules-2003-Updated-till-23-June-2017.pdf 
  12. Chaturvedi, Sachin. Kani Case. A Report for GenBenefit 2007 [cited 2024 Jun 27]. Available from: www.uclan.ac.uk/genbenefit.
  13. Kundailia N, Bose A, Saroch V, et al. Ayurveda and intellectual property rights (IPR). JAHM 2014;2(1):47-56.
  14. Gaudilliere JP. An Indian path to biocapital? The traditional knowledge digital library, drug patents, and the reformulation regime of contemporary Ayurveda. East Asian Sci Technol Soc 2014;8(4):391-415. 
  15. Tripathi KK. "Biotechnology: Government of India Initiatives". Indian Investment Center News Letter (Ministry of Finance); 2001a; p. 4-9.
  16. Tripathi K. Biotechnology and IPR Regime: In the Context of India and Developing Countries [Internet]. Available from: https://ris.org.in/sites/ default/files/article1_v7n2.pdf 
  17. Chaudhary A, Singh N. Intellectual property rights and patents in perspective of Ayurveda AYU 2012;33(1):20-26. 
  18. Halliburton M. India and the patent wars: pharmaceuticals in the new intellectual property regime. Ithaca: ILR Press; 2017.
  19. Reddy S. “Making Heritage Legible: Who Owns Traditional Medical Knowledge?” International Journal of Cultural Property 2006;13:161-188.
  20. Kline, Nathan. Use of Rauwolfia Serpentia Benth in neuropsychiatric conditions. Ann N Y Acad Sci 1954;59:107-132.
  21. Kaplan H, Sadock B. Comprehensive Textbook of Psychiatry. 6th Ed. Baltimore: Williams & Wilkins; 1995. 
  22. Kline N. The challenge of the psychopharmaceuticals. Proceedings of the American Philosophical Society 1959;103(3):455-462.
  23. Chandola HM. New challenges for Ayurveda: How it will stand? Ayu 2012;33(2):165-6.
  24. WHO. General guidelines for methodologies on research and evaluation of traditional medicine. Geneva: World Health Organization; 2000. 
  25. WHO. Proceedings of WHO symposium on traditional medicine. Japan: WHO Kobe Centre; 2000.
  26. Shankar D. Conceptual frame work for new models of integrative medicine. J Ayurveda Integr Med 2010;1:3-6.
  27. Singh RH. Exploring issues in the development of Ayurvedic research methodology. J Ayurveda Integr Med 2010;1(2):91-5.
  28. Singh RH, Narsimhamurthy K, Singh G. Neuronutrient impact of Ayurvedic rasayana therapy in brain aging. Biogerontology 2008;9:369-74.
  29. Smit HF, Woerdenbag HJ, Singh RH, et al. Ayurvedic herbal drugs with possible cytostatic activity. J Ethnopharmacol 1995;47:75-84.
  30. Patwardhan B. Ayurveda and integrative medicine: Riding a tiger. J Ayurveda Integr Med 2010;1:13-5. 
HealthMinds Logo
RGUHS Logo

© 2024 HealthMinds Consulting Pvt. Ltd. This copyright specifically applies to the website design, unless otherwise stated.

We use and utilize cookies and other similar technologies necessary to understand, optimize, and improve visitor's experience in our site. By continuing to use our site you agree to our Cookies, Privacy and Terms of Use Policies.